SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

NECTAR LIFESCIENCES

BSE: 532649 29 Jul 2025
Healthcare
₹ 18
Nectar Lifesciences Limited specializes in Pharmaceuticals within the Healthcare sector.

NECTAR LIFESCIENCES - Share Price & Details

Market Cap
₹519.0
High /Low
56.5 / 20.0
Stock P/E
30.5
Book Value
₹48.1
Dividend Yield
0.0
ROCE
5.97
ROE
₹0.46
Face Value
1.0
PEG Ratio
-0.83
EVEBITDA
₹6.29
Debt
629
CMP / FCF
3.19
Debt to equity
₹0.58
NP Ann
5.00
High price all time
60.9
Piotroski score
₹8.0
Graham Number
28.6
No. Eq. Shares
22.4
Net CF
₹2.23
Net profit
17.0
Price to book value
0.48
Interest Coverage
₹1.46
Low price all time
7.1
Industry PE
34.1
Reserves
₹1,055
Free Cash Flow
₹195

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.4691.0
Triochem Products Ltd.,3.25-4.52NA-18.440
NECTAR LIFESCIENCES LTD.4307.72-1300.894306.95-5.8519.030.5
MEDICAMEN BIOTECH LTD.312.1524.10259.951.9051778.8
ALBERT DAVID LTD.697.79-103.28748.93-18.1051230.1

Peer Comparison Chart


About NECTAR LIFESCIENCES

Nectar Lifesciences Limited, with Security Code 532649, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Macro Trends and Their Impact on Nectar Lifesciences Limited (NECLIFE) - Tremendous gains

(23 Jul 2025)
Macro Trends and Their Impact on Nectar Lifesciences Limited (NECLIFE) ✌️【Stock Buzz】✌️ Leverage expert insights to make smarter trades in...
Read more →

Macro Trends and Their Impact on Nectar Lifesciences Limited (NECLIFE) - Free Consultation

(23 Jul 2025)
Macro Trends and Their Impact on Nectar Lifesciences Limited (NECLIFE) ✌️【Stock Observations】✌️ Whether you're new to trading or a seasoned...
Read more →

Nectar Lifesciences Limited (NECLIFE) Gets Regulatory Approval - Skyrocketing investment returns

(23 Jul 2025)
Nectar Lifesciences Limited (NECLIFE) Gets Regulatory Approval ✌️【Market Discussions】✌️ We break down complex market trends and deliver...
Read more →

Nectar Lifesciences Limited (NECLIFE) Gets Regulatory Approval - Dynamic profit expansion

(21 Jul 2025)
Nectar Lifesciences Limited (NECLIFE) Gets Regulatory Approval ✌️【Market Insights】✌️ Our research team dives deep into balance sheets,...
Read more →

Nectar Lifesciences tanks around 20%, hits 52-week low after announcing ₹1,270 crore biz sale to Ceph Lifesciences

(10 Jul 2025)
Nectar Lifesciences Ltd. shares fell nearly 20% to ₹18.60 after announcing the sale of its API and formulations business to Ceph...
Read more →

Nectar Lifesciences shares drop 15% after announcing sale of core business for ₹1,270 crore

(10 Jul 2025)
Nectar Lifesciences Ltd. on Tuesday, July 8, said it has signed a definitive business transfer agreement for the sale of its core business...
Read more →

Company Updates